title: Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin.
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: T
authors.initials: T
authors.lastname: Honda
authors.forename: T
authors.initials: T
authors.lastname: Matsushita
authors.forename: T
authors.initials: T
authors.lastname: Kojima
authors.forename: J
authors.initials: J
authors.lastname: Takamatsu
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D005167:Factor VII / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression / Q000187:drug effects; D006467:Hemophilia A / Q000097:blood* / Q000150:complications / Q000188:drug therapy*; D002836:Hemophilia B / Q000097:blood* / Q000150:complications / Q000188:drug therapy*; D016174:Hepacivirus / Q000187:drug effects; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000150:complications / Q000188:drug therapy*; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D012254:Ribavirin / Q000494:pharmacology*
chemical_list: D000998:Antiviral Agents; D012333:RNA, Messenger; D012254:Ribavirin; D005167:Factor VII